NetworkNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) to Present at H.C. Wainwright Global Investment Conference
Calidi Biotherapeutics (NYSE American: CLDI), announced that CEO Eric Poma, Ph.D., will present at the H.C. Wainwright 27th Annual Global Investment Conference, taking place Sept. 8-10, 2025, at the Lotte New York Palace Hotel in New York. An on-demand presentation will be available starting Sept. 5 at 7 a.m. ET, highlighting Calidi’s RedTail platform, which is designed to protect virus from immune clearance, induce tumor lysis, and deliver therapeutic genetic medicines to metastatic sites through systemic administration. To view the full press release, visit https://nnw.fm/uTZqB About Calidi Biotherapeutics Calidi Biotherapeutics (NYSE American: CLDI) is a clinical-stage immuno-oncology company pioneering the…







